e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tyk2 as a target for immune regulation in human viral/bacterial pneumonia
Johanna Berg, Katja Zscheppang, Diana Fatykhova, Mario Tönnies, Torsten T. Bauer, Paul Schneider, Jens Neudecker, Jens C. Rückert, Stephan Eggeling, Maria Schimek, Achim D. Gruber, Norbert Suttorp, Stefan Hippenstiel, Andreas C. Hocke
Source:
Eur Respir J, 50 (1) 1601953; 10.1183/13993003.01953-2016
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Johanna Berg, Katja Zscheppang, Diana Fatykhova, Mario Tönnies, Torsten T. Bauer, Paul Schneider, Jens Neudecker, Jens C. Rückert, Stephan Eggeling, Maria Schimek, Achim D. Gruber, Norbert Suttorp, Stefan Hippenstiel, Andreas C. Hocke. Tyk2 as a target for immune regulation in human viral/bacterial pneumonia. Eur Respir J, 50 (1) 1601953; 10.1183/13993003.01953-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
A novel immune regulatory function of neutrophils in rhinovirus infections
Source: Lung Science Conference 2015
Year: 2015
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
LSC Abstract – A novel immune regulatory function of neutrophils in rhinovirus infections
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
miRNAs and the regulation of the lung innate immune response
Source: Annual Congress 2009 - miRNAs in inflammation and disease
Year: 2009
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia
Source: Eur Respir J 2013; 41: 384-391
Year: 2013
Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
The role of CARD9 in Pneumocystis host defense
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
The innate immune response to rhinovirus in bronchial epithelial cells is predominately controlled by signalling initiated via MDA-5
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
Microbiota educates innate immune response to Toll-like receptors stimulation and RSV infection in lung
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019
Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005
FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Breathprints of model murine bacterial lung infections are linked with immune response
Source: Eur Respir J 2015; 45: 181-190
Year: 2015
LSC 2012 abstract – FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells during bacterial infection
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012
UPF1 and STAU1 modulate rhinovirus pathophysiology contributing to impaired antiviral immunity in asthma
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Innate immune response of the lung to bacterial and viral stimuli: evidence for a role of epithelial toll-like receptor (TLR) 4 and TLR3
Source: Eur Respir J 2004; 24: Suppl. 48, 210s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept